Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec 19;5(2):ofx270.
doi: 10.1093/ofid/ofx270. eCollection 2018 Feb.

Potential Adverse Effects of Broad-Spectrum Antimicrobial Exposure in the Intensive Care Unit

Jenna Wiens  1 , Graham M Snyder  2   3 , Samuel Finlayson  3 , Monica V Mahoney  4 , Leo Anthony Celi  5   6
Affiliations

Potential Adverse Effects of Broad-Spectrum Antimicrobial Exposure in the Intensive Care Unit

Jenna Wiens et al. Open Forum Infect Dis. .

Abstract

Background: The potential adverse effects of empiric broad-spectrum antimicrobial use among patients with suspected but subsequently excluded infection have not been fully characterized. We sought novel methods to quantify the risk of adverse effects of broad-spectrum antimicrobial exposure among patients admitted to an intensive care unit (ICU).

Methods: Among all adult patients admitted to ICUs at a single institution, we selected patients with negative blood cultures who also received ≥1 broad-spectrum antimicrobials. Broad-spectrum antimicrobials were categorized in ≥1 of 5 categories based on their spectrum of activity against potential pathogens. We performed, in serial, 5 cohort studies to measure the effect of each broad-spectrum category on patient outcomes. Exposed patients were defined as those receiving a specific category of broad-spectrum antimicrobial; nonexposed were all other patients in the cohort. The primary outcome was 30-day mortality. Secondary outcomes included length of hospital and ICU stay and nosocomial acquisition of antimicrobial-resistant bacteria (ARB) or Clostridium difficile within 30 days of admission.

Results: Among the study cohort of 1918 patients, 316 (16.5%) died within 30 days, 821 (42.8%) had either a length of hospital stay >7 days or an ICU length of stay >3 days, and 106 (5.5%) acquired either a nosocomial ARB or C. difficile. The short-term use of broad-spectrum antimicrobials in any of the defined broad-spectrum categories was not significantly associated with either primary or secondary outcomes.

Conclusions: The prompt and brief empiric use of defined categories of broad-spectrum antimicrobials could not be associated with additional patient harm.

Keywords: antibiotic stewardship; antimicrobials; broad-spectrum; intensive care unit; nosocomial.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The number of patients among the study population who received ≥1 antimicrobials in 1, 2, 3, 4, or 5 categories of broad-spectrum antimicrobial.
Figure 2.
Figure 2.
Distribution of antimicrobials by spectrum of activity category over time. The plot indicates the fraction of the study population receiving at least 1 antimicrobial with the defined spectrum of coverage at anytime during the first 4 days after enrollment. In the case of Gram-negative agents, data represented are for the fraction of patients receiving 1 or more antimicrobials with activity against Gram-negative bacteria. Abbreviation: MRSA, methicillin-resistant Staphylococcus aureus.
See this image and copyright information in PMC

References

    1. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115:462–74. - PubMed
    1. Harbarth S, Garbino J, Pugin J et al. . Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003; 115:529–35. - PubMed
    1. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388–416. - PubMed
    1. Kumar A, Ellis P, Arabi Y et al. ; Cooperative Antimicrobial Therapy of Septic Shock Database Research Group Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 2009; 136:1237–48. - PubMed
    1. Kumar A, Safdar N, Kethireddy S, Chateau D. A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study. Crit Care Med 2010; 38:1651–64. - PubMed

LinkOut - more resources